Home
Conditions
Lymphoma, T-Cell

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

NCT01796002

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: ZNA Stuivenberg Antwerp, Belgium

A.Z. Sint Jan AV Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

UCL Louvain Saint Luc Brussels, Belgium

View all 131 locations

View Trial Details

Completed

Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides

NCT03281811

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

View Trial Details

Completed

Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome

NCT04185220

Conditions: Adult T-Cell Lymphoma/Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

NCT02643303

Conditions: Adenocarcinoma, Bladder Cancer, Breast Cancer, +65 more
Locations: Research Facility Atlanta, Georgia, United States

Research Facility Lebanon, New Hampshire, United States

Research Facility Buffalo, New York, United States

Research Facility New York, United States

View Trial Details

Completed

Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies

NCT01947140

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +44 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Columbia University Irving Medical Center New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia

NCT00053157

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, Chronic Disease, +55 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults

NCT00199082

Conditions: Burkitt Lymphoma, Burkitt's Leukemia, Burkitt's Lymphoma, +30 more
Locations: University Hospital, Medical Dept. II Frankfurt, Germany

View Trial Details

Completed

Vinorelbine for Recurrent ACLC

NCT03397953

Conditions: Anaplastic Large Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
Locations: Shanghai Children's Medical Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Dermoscopic Findings of Small Plaque Parapsoriasis and Patch Stage Mycosis Fungoides and Histopathological Correlation

NCT05433727

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations: Istanbul Teaching and Research Hospital Istanbul, Istanbul/Fatih, Turkey (Türkiye)

View Trial Details

Completed

Copanlisib and Gemcitabine in Relapsed/Refractory PTCL

NCT03052933

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Chonnam National University Hwasun Hospital Hwasun-gun, Jeollanam-do, South Korea

View Trial Details

Lymphoma, T-Cell

Lymphoma, T-Cell trial results

Related conditions